DMII Drugs Made In America Acquisition II Corp. Ordinary Shares

Financial Services

$10.07+0.10%ClosedMarket Cap: $528.8M

As of 2026-05-26

Valuation

P/E (TTM)

—

PEG

—

P/B

0.01

P/S

0.00

EV/EBITDA

-4.62

DCF Value

—

FCF Yield

-13.8%

Div Yield

0.0%

Margins & Returns

Gross Margin

0.0%

Operating Margin

0.0%

Net Margin

0.0%

ROE

2.3%

ROA

1.7%

ROIC

-0.3%

Income Statement

Periods shown are fiscal year quarters (may differ from calendar year)

Period	Revenue	Gross Margin	Operating Income	Net Income	EPS	Dividend
Q1 null	$0.00	NaN%	$-132.0K	$4.3M	$—	—
Q4 null	$0.00	NaN%	$-1.0M	$4.3M	$—	—
FY null	$0.00	NaN%	$-1.3M	$4.2M	$—	—
Q3 null	$0.00	NaN%	$-155.5K	$-46.2K	$—	—
Q2 null	$0.00	NaN%	$-38.1K	$-38.1K	$—	—
Q1 null	$0.00	NaN%	$-59.3K	$-59.3K	$—	—
FY null	$0.00	NaN%	$-151.7K	$-151.7K	$—	—
Q3 null	$0.00	NaN%	$-41.7K	$-41.7K	$—	—